Gene Data From HGNC: https://www.genenames.org/download/statistics-and-files/
Symbol:
PRCC
Name:
proline rich mitotic checkpoint control factor
Location:
01q23.1
Locus Group:
protein-coding gene
Gene Type:
Protein Coding
Locus Type:
gene with protein product
Clinical Trials Data: https://classic.clinicaltrials.gov/api/gui/ref/download_all
Clinical Studies
| NCT Number | Status | Brief Title | View |
|---|---|---|---|
| NCT03182530 | Prevention of Radial Artery Occlusion After Trans-radial Cardiac Catheterization | View | |
| NCT02127710 | A Phase II Trial to Evaluate the Efficacy of AZD6094 HMPL-504 in Patients With Papillary Renal Cell Carcinoma PRCC | View | |
| NCT05411081 | Testing Cabozantinib With or Without Atezolizumab in Patients With Advanced Papillary Kidney Cancer PAPMET2 Trial | View | |
| NCT03091192 | Savolitinib vs Sunitinib in MET-driven PRCC | View | |
| NCT06146777 | Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant Therapy | View | |
| NCT05665361 | Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma ccRCC or Papillary Renal Cell Carcinoma pRCC | View | |
| NCT05043090 | Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven Unresectable and Locally Advanced or Metastatic PRCC | View | |
| NCT05096390 | Axitinib - Pembrolizumab in First Line Treatment of mPRCC | View | |
| NCT02489695 | Axitinib in1st Line Treatment for Patients With Advanced or Metastatic Papillary Renal Cell Carcinoma | View |